Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
HIMS 
Hims Hers Health Inc (HIMS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: HIMS (3-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
13 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $47.08
1 Year Target Price $47.08
| 4 | Strong Buy |
| 1 | Buy |
| 6 | Hold |
| 1 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 104.16% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.88B USD | Price to earnings Ratio 82.51 | 1Y Target Price 47.08 |
Price to earnings Ratio 82.51 | 1Y Target Price 47.08 | ||
Volume (30-day avg) 13 | Beta 2.4 | 52 Weeks Range 19.15 - 72.98 | Updated Date 11/6/2025 |
52 Weeks Range 19.15 - 72.98 | Updated Date 11/6/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.53 |
Earnings Date
Report Date 2025-11-03 | When - | Estimate 0.0957 | Actual 0.06 |
Profitability
Profit Margin 9.61% | Operating Margin (TTM) 4.91% |
Management Effectiveness
Return on Assets (TTM) 6.94% | Return on Equity (TTM) 41.88% |
Valuation
Trailing PE 82.51 | Forward PE 81.3 | Enterprise Value 12979526152 | Price to Sales(TTM) 4.5 |
Enterprise Value 12979526152 | Price to Sales(TTM) 4.5 | ||
Enterprise Value to Revenue 6.45 | Enterprise Value to EBITDA 83.86 | Shares Outstanding 217641958 | Shares Floating 204265196 |
Shares Outstanding 217641958 | Shares Floating 204265196 | ||
Percent Insiders 6.34 | Percent Institutions 82.28 |
Upturn AI SWOT
Hims Hers Health Inc
Company Overview
History and Background
Hims & Hers Health, Inc. was founded in 2017, initially focused on men's wellness and has since expanded to include women's health. It started as a direct-to-consumer telehealth platform offering prescription medications and personal care products. It went public in 2021 via a SPAC merger.
Core Business Areas
- Telehealth Services: Offers online consultations with healthcare providers for various conditions, including hair loss, erectile dysfunction, skincare, and mental health. Prescriptions are fulfilled and shipped directly to customers.
- Subscription-Based Products: Provides recurring deliveries of prescription medications and over-the-counter products through subscription plans. This ensures consistent treatment and drives recurring revenue.
- Wholesale: Hims & Hers products are now also sold through wholesale channels such as Walmart, CVS, Target, Walgreens, etc.
Leadership and Structure
Andrew Dudum is the CEO. The company has a typical corporate structure with departments for marketing, technology, operations, and finance.
Top Products and Market Share
Key Offerings
- Hair Loss Treatment: Offers prescription medications like finasteride and minoxidil, as well as over-the-counter shampoos and conditioners. Competitors include Keeps, Rogaine, and Roman. Hard to get a specific market share for Hims & Hers due to it being a broad market, but revenue in 2023 reached over $1 billion.
- Erectile Dysfunction Treatment: Provides prescription medications like sildenafil (generic Viagra) and tadalafil (generic Cialis) through online consultations. Competitors include Roman and traditional brick-and-mortar pharmacies. Hard to get a specific market share for Hims & Hers due to it being a broad market, but revenue in 2023 reached over $1 billion.
- Skincare Products: Offers a range of skincare products addressing issues like acne, aging, and dryness. Competitors include Curology and traditional skincare brands. Hard to get a specific market share for Hims & Hers due to it being a broad market, but revenue in 2023 reached over $1 billion.
- Mental Health Services: Offers online therapy and prescription medications for anxiety and depression. Competitors include Talkspace and Cerebral. Hard to get a specific market share for Hims & Hers due to it being a broad market, but revenue in 2023 reached over $1 billion.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth, driven by increased access to technology, changing consumer preferences, and a growing demand for convenient and affordable healthcare. The market is becoming increasingly competitive, with many new players entering the space.
Positioning
Hims Hers Health Inc positions itself as a convenient and affordable provider of personalized healthcare solutions. Its competitive advantages include its strong brand recognition, direct-to-consumer business model, and subscription-based revenue stream.
Total Addressable Market (TAM)
The TAM for telehealth is estimated to be in the hundreds of billions of dollars. Hims Hers Health Inc is positioned to capture a significant share of this market by expanding its product offerings and targeting new customer segments.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Direct-to-consumer business model
- Subscription-based revenue stream
- Convenient and affordable access to healthcare
- Expansion into women's health
Weaknesses
- Reliance on prescription medications
- Regulatory risks associated with telehealth
- Competition from established healthcare providers
- Marketing costs for customer acquisition are high
Opportunities
- Expansion into new product categories
- Partnerships with healthcare providers and insurers
- International expansion
- Increased adoption of telehealth
- Growth in mental health awareness
Threats
- Increased competition
- Changes in regulations
- Negative publicity
- Data security breaches
- Economic downturn affecting consumer spending
Competitors and Market Share
Key Competitors
- AMZN
- CVS
- VRTV
Competitive Landscape
Hims Hers Health Inc competes with traditional healthcare providers, other telehealth companies, and retailers. It differentiates itself through its strong brand, direct-to-consumer model, and subscription-based service.
Growth Trajectory and Initiatives
Historical Growth: Hims Hers Health Inc has experienced rapid revenue growth since its inception.
Future Projections: Analysts project continued revenue growth for Hims Hers Health Inc, driven by increased adoption of telehealth and expansion into new markets.
Recent Initiatives: Recent initiatives include expanding into women's health, launching new products, and partnering with retailers.
Summary
Hims & Hers Health Inc is a rapidly growing telehealth company with a strong brand and a direct-to-consumer model. While not yet profitable, revenue is increasing. The company needs to navigate the competitive landscape and regulatory risks. It is positioned to capture a share of the growing telehealth market.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q), Investor Presentations, Analyst Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Hims Hers Health Inc
Exchange NYSE | Headquaters San Francisco, CA, United States | ||
IPO Launch date 2019-09-13 | Co-Founder, Chairman & CEO Mr. Andrew Dudum | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 1637 | Website https://www.hims.com |
Full time employees 1637 | Website https://www.hims.com | ||
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.